Head-to-head dispatch
Sunlight vs TRYM Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A LegitScript-certified compounded GLP-1 telehealth brand with flat, openly published pricing — semaglutide from $88/mo, tirzepatide from $157/mo — plus a separate peptide-therapy program (NAD+, and per the live site, sermorelin) under its own intake.
Marked down on: Injectable only for GLP-1 — no oral tablet route on semaglutide or tirzepatide, despite a generic "Injections and oral options available" line in one landing page's hero that matches nothing else on the site
Desk Score
TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose…
Marked down on: Compounding pharmacy partner not named
FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.
Sunlight takes this head-to-head with the higher Desk Score, 84/100 (B) against 66/100 (C) for TRYM Health. TRYM Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Sunlight
84/100
B
TRYM Health
66/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Sunlight | TRYM Health |
|---|---|---|
| Semaglutide | Starts at $88/mo (compounded, injection) | $96/mo (all doses, compounded) |
| Tirzepatide | Starts at $157/mo (compounded, injection) | $126/mo (all doses, compounded) |
| Coverage | All 50 states (varies by provider licensure) | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route. | Readers who want budget-focused shoppers wanting low-cost compounded GLP-1 vials shipped nationwide. |
| Desk Score | 84/100B | 66/100C |
The verdict
Desk pick — SunlightSunlight takes this head-to-head with the higher Desk Score, 84/100 (B) against 66/100 (C) for TRYM Health. TRYM Health still holds its ground where its strengths line up with yours.
Choose Sunlight if…
Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route.
Starts at $88/mo (compounded, injection) sema · Starts at $157/mo (compounded, injection) tirz · All 50 states (varies by provider licensure)
Choose TRYM Health if…
Readers who want budget-focused shoppers wanting low-cost compounded GLP-1 vials shipped nationwide.
$96/mo (all doses, compounded) sema · $126/mo (all doses, compounded) tirz · Coverage not published
FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Sunlight · TRYM Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Sunlight vs CoreAge Rx
- TRYM Health vs Vaylen
- Sunlight vs Strut Health
- TRYM Health vs Ondra Health
- Sunlight vs Invigor Medical
- TRYM Health vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.